Ignite Creation Date:
2024-05-06 @ 7:38 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02576431
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2015-10-12
Brief Title:
A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Sponsor:
Bayer
Organization:
Bayer
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumors Harboring NTRK Fusion |
Keywords:
| Name | View |
|---|---|
| ETV6 | View |
| Non-small cell lung cancer | View |
| Thyroid cancer | View |
| Sarcoma | View |
| Colorectal cancer | View |
| Salivary gland cancer | View |
| Biliary cancer | View |
| Central nervous system CNS Tumor | View |
| Breast cancer | View |
| Melanoma | View |
| Neurotrophic tyrosine receptor kinase NTRK | View |
| NTRK1 | View |
| NTRK2 | View |
| NTRK3 | View |
| Fusion Positive | View |
| TRK fusion | View |
| TRKA | View |
| TRKB | View |
| TRKC | View |